LFMD LifeMD, Inc.
Healthcare$4.24+1.19%ClosedMarket Cap: $205.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
13.19
P/S
0.92
EV/EBITDA
-40.56
DCF Value
$-17.06
FCF Yield
7.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.9%
Operating Margin
-5.9%
Net Margin
-7.4%
ROE
-172.3%
ROA
-23.2%
ROIC
-60.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $50.2M | 84.8% | $-8.9M | $-8.9M | $— | — |
| Q4 null | $46.9M | 81.8% | $-1.1M | $-1.5M | $— | — |
| FY null | $194.1M | 79.8% | $-7.7M | $-7.1M | $— | — |
| Q3 null | $60.2M | 87.7% | $-2.0M | $-3.8M | $— | — |
| Q2 null | $62.2M | 88.1% | $-906.8K | $-2.1M | $— | — |
| Q1 null | $65.7M | 86.8% | $2.5M | $1.4M | $— | — |
| Q4 null | $64.3M | 85.3% | $1.0M | $-106.3K | $— | — |
| FY null | $212.5M | 88.7% | $-16.1M | $-18.9M | $— | — |
| Q3 null | $53.3M | 90.6% | $-4.0M | $-4.7M | $— | — |
| Q2 null | $50.7M | 90.1% | $-6.3M | $-6.9M | $— | — |
| Q1 null | $44.1M | 89.6% | $-6.2M | $-6.8M | $— | — |
| Q4 2023 | $44.9M | 88.1% | $-2.2M | $-3.7M | $-0.10 | — |